• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Bionomics Ltd

+ Add to Watchlist


0.5300 AUD 0.0050 0.93%

As of 02:10:58 ET on 07/11/2014.

Snapshot for Bionomics Ltd (BNO)

Open: 0.5450 Day's Range: 0.5250 - 0.5450 Volume: 241,232
Previous Close: 0.5350 52wk Range: 0.3400 - 0.8900 1-Yr Rtn: +55.88%

Stock Chart for BNO

No chart data available.
  • BNO:AU 0.5300
  • 1D
  • 1M
  • 1Y
Interactive BNO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BNO

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 176.6667
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.0323
Est. EPS (AUD) (06/2014) 0.0030
Est. PEG Ratio -
Market Cap (M AUD) 221.20
Shares Outstanding (M) 417.36
30 Day Average Volume 451,908
Price/Book (mrq) 6.2055
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BNO

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for BNO

Bionomics Limited operates as a biotechnology company, which specializes in the genetics field. The Company, which is affiliated with a number of research institutions, seeks to develop a variety of genomic, genetic, molecular and cell biology techniques, which they believe will help demonstrate the onset and progression of diseases like epilepsy and breast cancer.

Deborah RathjenManaging Director/CEOMelanie YoungCFO/Secretary
Jose IglesiasChief Medical Officer
More Company Profile & Key Executives for BNO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil